Amedisys Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Amedisys (AMED) Tops Q1 EPS by 11c
April 29, 2015 7:10 AM EDTAmedisys (NASDAQ: AMED) reported Q1 EPS of $0.31, $0.11 better than the analyst estimate of $0.20. Revenue for the quarter came in at $301.6 million versus the consensus estimate of $300.17 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More